| Previous close | 177.50 |
| Open | 177.50 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 860.00 |
| Expiry date | 2025-12-19 |
| Day's range | 177.50 - 177.50 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Yahoo FinanceWeight-loss drug competition heats up with growing pill market
GLP-1 pills are the next frontier for the weight-loss market.
Simply Wall St.Eli Lilly (NYSE:LLY) Gains FDA Approval for EBGLYSS, Expands Strategic Alliances for Market Growth
Eli Lilly(NYSE:LLY) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a robust 36% surge in Q2 revenue, driven by new product launches, contrasted against supply constraints and a significant decline in Trulicity revenue.
Insider MonkeyJim Cramer Shows Confidence In The Eli Lilly and Company (LLY)’s Future Growth
We recently published a list of Must-See: Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other Jim Cramer’s best stocks for investors. In a recent episode of Mad Money, Jim Cramer discussed how the slowing economy […]
© 2024 Yahoo. All rights reserved.